Dr. Gary Goldenberg, MD

Bio

Gary Goldenberg, M.D., is the Medical Director of the Dermatology Faculty Practice at The Mount Sinai Medical Center and an Assistant Professor of Dermatology and Pathology at Icahn School of Medicine at Mount Sinai in New York City.

Dr. Goldenberg received his medical degree from Temple University School of Medicine.  He completed his residency in Dermatology at Wake Forest University School of Medicine and a Dermatopathology Fellowship at University of Colorado Health Sciences Center. Board certified in Dermatology and Dermatopathology, Dr. Goldenberg provides comprehensive dermatological care in medical and cosmetic dermatology, including skin cancer, nevi, psoriasis, eczema, sexually transmitted diseases, acne, cosmetic injections, and laser surgery.

An active investigator, Dr. Goldenberg’s research interests include skin cancer, psoriasis, eczema, and acne. He is the author of over 50 original articles, abstracts and book chapters.  He serves on editorial boards and as a reviewer for multiple dermatology journals, and he regularly lectures at the American Academy of Dermatology meetings, as well as regional dermatology meetings.

Dr. Goldenberg is a member of many professional organizations, including American Academy of Dermatology, American Society of Dermatopathology, and the Treasurer and member of the Board of Directors for the Dermatologic Society of Greater New York. He has also received numerous awards and honors including Alpha Omega Alpha Medical Honor Society, Mentor of the Year, Wake Forest Dermatology First Annual Dermatology Resident Teaching Award, and the American Academy of Dermatology’s Academic Dermatology Leadership Program.

Specialties:

  • dermatology

Affiliation:

  • The Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai

Group Memberships:

Activity

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    THURSDAY, Dec. 18, 2014 (HealthDay News) -- Common painkillers, including ibuprofen, might slightly reduce your risk of developing a form of skin cancer, researchers say.

    Use of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to reduce the risk of squamous cell skin cancer by 15 per...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, Dec. 17, 2014 (HealthDay News) -- Airline pilots get as much exposure to cancer-causing UV rays in an hourlong flight as they would during 20 minutes in a tanning bed, new research finds.

    The study, led by Dr. Martina Sanlorenzo, from the University of California, San Francisco...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, Nov. 19, 2014 (HealthDay News) -- New research suggests that genes tied to blue eyes and red hair could put people at higher risk for moles or freckling in childhood, which are often precursors to the deadly skin cancer melanoma later in life.

    Howeve...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    TUESDAY, Nov. 4, 2014 (HealthDay News) -- Patients with advanced melanoma may live longer when treated with a combination of the cancer drug Yervoy and the immune system booster sargramostim, a new study finds.

    Patients given the two drugs had a median survival of 17.5 months, compared to...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, Oct. 22, 2014 (HealthDay News) -- While in-office visits may still be best, taking a photo of a skin lesion and sending it to your dermatologist for analysis may be a valuable piece of eczema care, a new study finds.

    "This study shows something interesting -- patients' eczema ...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    FRIDAY, Sept. 19, 2014 (HealthDay News) -- U.S. military troops deployed to sunny climates may have an increased risk of skin cancer, according to a new study.

    Many returning troops reported getting sunburned while serving abroad, researchers revealed. In some cases, military personnel d...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    FRIDAY, Sept. 5, 2014 (HealthDay News) -- A growing knowledge of the skin disease called psoriasis is leading to greater treatment choices, including personalized therapies, the U.S. Food and Drug Administration reports.

    Psoriasis is an immune system disorder that causes overproduction of...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Sept. 4, 2014 (HealthDay News) -- Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced melanoma, a deadly form of skin cancer.

    Melanoma, accounting for about 5 percent of new cancers in the United States, is expected to be diagnos...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, Sept. 3, 2014 (HealthDay News) -- Airline pilots and flight crews may face as much as twice the risk of the type of skin cancer known as melanoma compared with the general population, according to a new analysis of existing research.

    However, it's not clear whether exposure to...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- The speed at which cancer cells grow may help doctors diagnose and treat the most aggressive melanomas, researchers say.

    Using this measure, investigators have found that the deadliest skin cancers occur most often on the head and neck of olde...Full Article

  • Sharecare News
    Sharecare News posted a story about Cosmetology:

    THURSDAY, Aug. 14, 2014 (HealthDay News) -- Injectable dermal fillers are widely used by people seeking to smooth out wrinkles, but it's important to know the risks of these products before using them, a U.S. government expert says.

    Dermal fillers use a variety of materials to treat facia...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    THURSDAY, Aug. 7, 2014 (HealthDay News) -- The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.

    The drug is sanctioned to treat methicillin-resistant <...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    WEDNESDAY, July 23, 2014 (HealthDay News) -- Painful or itchy skin lesions could be a warning sign of skin cancer, researchers report.

    "Patients sometimes have multiple lesions that are suspicious looking, and those that are itchy or painful should raise high concerns for non-melanoma ski...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    MONDAY, July 21, 2014 (HealthDay News) -- A drug already used to treat moderate-to-severe allergic asthma appears to offer relief to people with chronic hives who haven't been helped by standard medications, new research suggests.

    The prescription drug -- omalizumab (Xolair) -- is already...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    THURSDAY, July 10, 2014 (HealthDay News) -- A new drug that scientists hope will relieve the debilitating itching of chronic eczema has shown promising results in early trials.

    Dupilumab, which is injected, interferes with the activity of two key proteins that play a critical role in the ...Full Article